R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.

R&D

Cardiometabolic disease is not a single entity. It is a broad spectrum of disorders that share common drivers.

R&D

Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.

R&D

Antimicrobial resistance (AMR) is a growing global health crisis.

R&D

Prive Bio CEO Laurent Audaly spoke with pharmaphorum during the JP Morgan Healthcare conference, discussing GLP-1s in the cardiometabolic space.

R&D

The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO changes at biotech firms.